Study of Radiology Manipulator Work Validation by the Radiologist
NCT06894082
Summary
The main objective of this study is to evaluate the pre-filling work on target and non-target lesions, and the detection of any new lesions reported by the MEM trained in protocol evaluations, in a structured table to prepare the radiologist's work in interpreting RECIST 1.1 scans. To meet this objective, patients taking part in the CIMER study will first have been included in a research protocol requiring scans with RECIST 1.1 interpretation. The Baseline examination will be performed and interpreted according to RECIST 1.1 without informing the radiologist performing the reading that the patient is included in the study, so as not to introduce an interpretation bias. During the first evaluation. The investigating MEM alone will carry out a preliminary analysis of the first evaluation and will present his results to the radiologist in charge of the evaluation, who will validate the conformity of the results.
Eligibility
Inclusion Criteria: * Male or female aged 18 and over * Patient included in a clinical research protocol in oncology for solid cancer including RECIST 1.1 interpretation * Disease measurable according to RECIST 1.1 * Patient not objecting to study participation * Member of a social security scheme, or beneficiary of such a scheme. Non inclusion Criteria: * Patients with lymphoma or leukemia * Patient contraindicated to iodinated contrast media injection * Person in an emergency situation, adult subject to a legal protection measure (major under guardianship, curatorship or safeguard of justice), or unable to express, his/her non-opposition to participate in the study * Unable to undergo medical follow-up for geographical, social or psychological reasons. or psychological reasons. Exclusion Criteria: * Patient with renal insufficiency or allergy during the trial no longer allowing injection of iodinated contrast medium * Patient refusing iodinated PDC injection during the study * Patient withdrawn from the study including scanner interpretation in Recist 1.1
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06894082